Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative oral steroids versus NSAIDs for post-endodontic pain in symptomatic irreversible pulpitis
IRCT20260722070301N1Phase 3Recruiting
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of naproxen, dexamethasone, prednisolone, piroxicam, diclofenac and 1 more in irreversible pulpitis (6 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoint: Postoperative pain. Started Aug 2026; status: recruiting.
02
Drugs
naproxendexamethasoneprednisolonepiroxicamdiclofenac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20260722070301N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260722070301N1.